AMR Conference 2025
NCCR AntiResist is delighted to be sponsoring the 9th AMR Conference again in 2025. The conference will take place on 25-26 February at the Congress Centre in Basel.
The program is live on the conference website, and abstract submissions are now open.
About the AMR Conference
The #AMRconference is a platform for SMEs, start-ups, big pharma, academia, investors and public institutions to discuss strategies and specific challenges faced by the innovation ecosystem in bringing new antimicrobial treatments and diagnostics to the market.
The conference is the one-stop shop to catch up with the latest trends in the development of AMR products, by covering scientific, regulatory, financial and policy topics. Besides high-level talks, the conference is a great place to network and exchange views on innovative technologies, development paths and alternative business models with your peers. The conference also offers a one-to-one partnering to facilitate interactions.
Once more, the 8th edition covered the whole innovation value chain, including scientific breakthrough, preclinical and clinical development, but also financial topics such as public funding for R&D, market incentive and investors’ perspective. Specific sessions were also dedicated to phage therapy, diagnostics, antifungals and anti-tuberculosis drug combinations. There was a special focus on One Health and on how artificial intelligence can foster prevention and smart use of antibiotics. Among other highlights were a start-up pitch, hosted by the pharma-backed incubator INCATE, and a presentation of scientific posters.
The AMR Conference is jointly organized by BEAM Alliance and bamconn GmbH.
The BEAM Alliance is one of the major supporting partners of the AMR Conference. Launched in June 2015, the BEAM (Biotech companies in Europe combating AntiMicrobial Resistance) Alliance gathers more than 70 small and medium-sized European biotech and diagnostics companies committed to developing innovative products for fending off antibiotic-resistant pathogens. BEAM Alliance carries the voice of SMEs to support policies and incentives in antimicrobial research and development in Europe.
bamconn GmbH was established in November 2022 as a spin-off of BIOCOM AG and continues its entire event management as an independent company. It is built on more than 15 years of experience in the planning, organization and implementation of scientific events and exhibitions. The portfolio covers the entire spectrum from small workshops with 20 participants to multi-day international conferences for up to 2,000 people as well as exhibitions on the topic of bioeconomy throughout Europe. Customers for whom the bamconn team worked so far are companies, research institutions, associations and federal ministries as well as subordinate authorities and EU-funded projects.
